Freenome is a health technology company bringing accurate, accessible and non-invasive disease screenings to you and your doctor to proactively treat cancer and other diseases at their most manageable stages.
Since the company’s, Freenome has had a clear vision – to reinvent disease management through early detection and intervention. And over the past three years, the Company's team has been tackling this long term goal by making cancer screening and diagnostics as accurate and accessible as possible, through a fusion of machine learning, biology and computer science.
Company Growth (employees)
Palo Alto, US
Size (employees)
31 (est)+7%
Freenome was founded in 2015 and is headquartered in Palo Alto, US

Freenome Office Locations

Freenome has an office in Palo Alto
Palo Alto, US (HQ)
2627 Hanover St

Freenome Data and Metrics

Summary Metrics

Freenome's latest funding round in March 2017 was reported to be $65 m. In total, Freenome has raised $70.6 m

Traffic Overview of Freenome

Freenome Online and Social Media Presence

Freenome News and Updates

In liquid biopsy race, Freenome lands $65 million, led by Andreessen Horowitz

 Freenome, a two-year-old liquid biopsy diagnosis platform that detects the cell-free DNA sequencing of cancer, has raised a huge Series A round — $65 million — led by Andreessen Horowitz, which also led the company’s $5.5 million seed round less than a year ago. Other investors in the deal include …

Freenome’s Gabriel Otte: AI In Healthcare Will Save Lives

Missed out on the Innovation Summit livestream? Sign up to receive the videos and presentation. AI, applied properly in healthcare, will save lives, said Freenome’s CEO Gabriel Otte. Freenome, an AI 100 startup working on cancer diagnostics, is backed by … Continued

Freenome Company Life and Culture

You may also be interested in